These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2499418

  • 21. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT, White KL.
    Cancer Res; 1988 Jan 01; 48(1):41-5. PubMed ID: 3257162
    [Abstract] [Full Text] [Related]

  • 22. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H, Jacob-Müller U.
    Teratology; 1981 Feb 01; 23(1):7-13. PubMed ID: 7245091
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Alkylation of guanosine and deoxyguanosine by phosphoramide mustard.
    Mehta JR, Przybylski M, Ludlum DB.
    Cancer Res; 1980 Nov 01; 40(11):4183-6. PubMed ID: 7471059
    [Abstract] [Full Text] [Related]

  • 25. Covalent sequestration of phosphoramide mustard by metallothionein--an in vitro study.
    Wei D, Fabris D, Fenselau C.
    Drug Metab Dispos; 1999 Jul 01; 27(7):786-91. PubMed ID: 10383921
    [Abstract] [Full Text] [Related]

  • 26. Nitroaryl phosphoramides as novel prodrugs for E. coli nitroreductase activation in enzyme prodrug therapy.
    Hu L, Yu C, Jiang Y, Han J, Li Z, Browne P, Race PR, Knox RJ, Searle PF, Hyde EI.
    J Med Chem; 2003 Nov 06; 46(23):4818-21. PubMed ID: 14584930
    [Abstract] [Full Text] [Related]

  • 27. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
    Ormstad K, Ohno Y.
    Cancer Res; 1984 Sep 06; 44(9):3797-800. PubMed ID: 6430554
    [Abstract] [Full Text] [Related]

  • 28. Comparative effects of cyclophosphamide, isophosphamide, 4-methylcyclophosphamide, and phosphoramide mustard on murine hematopoietic and immunocompetent cells.
    Sensenbrenner LL, Marini JJ, Colvin M.
    J Natl Cancer Inst; 1979 Apr 06; 62(4):975-81. PubMed ID: 285298
    [Abstract] [Full Text] [Related]

  • 29. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR, Souhami RL, McLean AE.
    Cancer Res; 1986 Oct 06; 46(10):5029-34. PubMed ID: 3463409
    [Abstract] [Full Text] [Related]

  • 30. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM, Wodinsky I, Myles A.
    Cancer Treat Rep; 1976 Apr 06; 60(4):337-46. PubMed ID: 1277209
    [Abstract] [Full Text] [Related]

  • 31. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
    Plowchalk DR, Mattison DR.
    Toxicol Appl Pharmacol; 1991 Mar 01; 107(3):472-81. PubMed ID: 2000634
    [Abstract] [Full Text] [Related]

  • 32. Comparison of in vitro effects of two thiol-containing drugs on human neutrophils hydrogen peroxide production.
    Gressier B, Cabanis A, Lebegue S, Brunet C, Dine T, Luyckx M, Cazin M, Cazin JC.
    Methods Find Exp Clin Pharmacol; 1993 Mar 01; 15(2):101-5. PubMed ID: 8487592
    [Abstract] [Full Text] [Related]

  • 33. Morphological and biochemical aspects of monofunctional phosphoramide mustard teratogenicity in rat embryos cultured in vitro.
    Mirkes PE, Greenaway JC, Hilton J, Brundrett R.
    Teratology; 1985 Oct 01; 32(2):241-9. PubMed ID: 4049282
    [Abstract] [Full Text] [Related]

  • 34. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
    Yuan ZM, Smith PB, Brundrett RB, Colvin M, Fenselau C.
    Drug Metab Dispos; 1991 Oct 01; 19(3):625-9. PubMed ID: 1680629
    [Abstract] [Full Text] [Related]

  • 35. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
    Low JE, Borch RF, Sladek NE.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5815-20. PubMed ID: 6640533
    [Abstract] [Full Text] [Related]

  • 36. Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds.
    Draeger J, Peter G, Hohorst HJ.
    Cancer Treat Rep; 1976 Apr 01; 60(4):355-9. PubMed ID: 1277211
    [Abstract] [Full Text] [Related]

  • 37. Analysis and excision of ring-opened phosphoramide mustard-deoxyguanine adducts in DNA.
    Chetsanga CJ, Polidori G, Mainwaring M.
    Cancer Res; 1982 Jul 01; 42(7):2616-21. PubMed ID: 7083154
    [Abstract] [Full Text] [Related]

  • 38. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
    Crook TR, Souhami RL, Whyman GD, McLean AE.
    Cancer Res; 1986 Oct 01; 46(10):5035-8. PubMed ID: 3463410
    [Abstract] [Full Text] [Related]

  • 39. Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.
    Zaharko DS, Covey JM, Hörpel G.
    Invest New Drugs; 1984 Oct 01; 2(2):149-54. PubMed ID: 6469508
    [Abstract] [Full Text] [Related]

  • 40. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity.
    Cai Y, Wu MH, Ludeman SM, Grdina DJ, Dolan ME.
    Cancer Res; 1999 Jul 01; 59(13):3059-63. PubMed ID: 10397244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.